Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail against serious diseases. Around the world, our medicines are helping millions of patients in their fight against such diseases as cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, psychiatric disorders and rheumatoid arthritis. Additionally, our philanthropic programs have given new hope to some of the world’s most vulnerable citizens.Since 2002, BMS globally has delivered 13 key new products to patients with serious diseases. Four of these medicines are biologic products. Additional biologic compounds – as well as scores of other investigational medicines – are advancing through the development pipeline. Bristol-Myers Squibb is recognized as having one of the most productive pipelines in the industry. To accelerate the discovery and development of important new therapies, we are complementing and enhancing our internal capabilities with our String of Pearls strategy of innovative alliances, partnerships and acquisitions. What sets us apart? At Bristol-Myers Squibb, we believe it’s our commitment to patients with serious diseases and our focus on finding innovative medicines to combat those diseases. As a BioPharma leader, Bristol-Myers Squibb has an exciting future. As we make a difference in the lives of patients, we say, “Together we can prevail.”

Show On Map